AxoGen (US.AXGN)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.AXGN · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 46.3% | ↓ |
| ROE | -8.2% | ↓ |
| Cash Conversion | - | → |
| D/E Ratio | 0.08 | ↑ |
| Gross Margin | 73.8% | → |
US.AXGN (AxoGen) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY --------------------------- FCF Conversion 46.3% ↓ ROE -8.2% ↓ Cash Conversion - → D/E Ratio 0.08 ↑ Gross Margin 73.8% →
Key Metrics
US.AXGN (AxoGen) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY---------------------------FCF Conversion 46.3% ↓ROE -8.2% ↓Cash Conversion - →D/E Ratio 0.08 ↑Gross Margin 73.8% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies